Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe
Features
Series
Themes
Community
Data
Subscribe Log In
More

Gates Foundation and Horizons Ventures invest in Evolve’s infant probiotic



California-based Evolve BioSystems is making a probiotic nutritional supplement for infants to fight child malnutrition. Evolve’s basis for the product, called Evivo, is research that points to infant gut health as important to fighting disease and preventing allergies and type 1 diabetes. The product launched last year in the U.S. and has recently been approved for sale in Canada.

  • Strategic investors… The Gates Foundation and Horizon Ventures, the venture investment arm of Hong Kong billionaire Li Ka-Shing’s foundation, have backed Evolve’s Series C round to help the company expand Evivo sales globally and plan new products. Horizons Ventures also invested in the company’s Series A round in 2015.
  • Back story… Evolve started in 2011 as a spinoff from the University of California, Davis’s Foods for Health Institute. It has raised $69 million in total to date.
  • Neglected no more… The Gates Foundation has invested a few hundred million dollars in more than a dozen biotech companies, many focused on solutions for neglected diseases in the developing world.

You might also like...